Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL). [electronic resource]
Producer: 19960705Description: 375-83 p. digitalISSN:- 0340-7004
- Animals
- Antigens, CD -- biosynthesis
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma -- drug therapy
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Cytotoxicity, Immunologic -- drug effects
- Dacarbazine -- administration & dosage
- Drug Administration Schedule
- Drug Screening Assays, Antitumor
- Drug Synergism
- Gene Expression Regulation, Neoplastic -- drug effects
- Immunologic Factors -- pharmacology
- Integrin alpha6
- Interleukin-2 -- pharmacology
- Lung Neoplasms -- drug therapy
- Male
- Mice
- Mice, Inbred C57BL
- Neoplasm Metastasis -- prevention & control
- Neoplasm Proteins -- biosynthesis
- Neoplasm Transplantation
- T-Lymphocytes, Cytotoxic -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.